IE40226B1 - M-dioxane-5-methylamine analgesics - Google Patents
M-dioxane-5-methylamine analgesicsInfo
- Publication number
- IE40226B1 IE40226B1 IE2190/73A IE219073A IE40226B1 IE 40226 B1 IE40226 B1 IE 40226B1 IE 2190/73 A IE2190/73 A IE 2190/73A IE 219073 A IE219073 A IE 219073A IE 40226 B1 IE40226 B1 IE 40226B1
- Authority
- IE
- Ireland
- Prior art keywords
- formula
- image
- analgesics
- methylamine
- dioxane
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/04—1,3-Dioxanes; Hydrogenated 1,3-dioxanes
- C07D319/06—1,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The m-dioxanes correspond to the formula I <IMAGE> the meanings of the symbols being given in Patent Claim 1. The compounds, as well as those which have been partially demethylated at the amine nitrogen, exhibit an excellent analgesic action without producing addiction in the treated patient. The compounds are prepared by reacting a ketone of the formula II <IMAGE> with an amine of the formula <IMAGE> and reducing the resulting enamine catalytically in the presence of hydrogen to give a compound of the formula I.
[GB1455997A]
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IE2342/77A IE40227B1 (en) | 1972-12-08 | 1973-12-04 | 2-(-(substituted) amino-benzyl)-1,3-propanediols |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31322172A | 1972-12-08 | 1972-12-08 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IE40226L IE40226L (en) | 1974-06-08 |
| IE40226B1 true IE40226B1 (en) | 1979-04-11 |
Family
ID=23214841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IE2190/73A IE40226B1 (en) | 1972-12-08 | 1973-12-04 | M-dioxane-5-methylamine analgesics |
Country Status (27)
| Country | Link |
|---|---|
| JP (2) | JPS5734835B2 (en) |
| AR (3) | AR206306A1 (en) |
| AT (2) | AT330773B (en) |
| BE (1) | BE808340A (en) |
| BG (4) | BG21223A3 (en) |
| CA (2) | CA1014560A (en) |
| CH (4) | CH614439A5 (en) |
| CS (3) | CS222208B2 (en) |
| CY (1) | CY1017A (en) |
| DD (3) | DD115653A5 (en) |
| DE (1) | DE2361340C2 (en) |
| DK (1) | DK134717B (en) |
| ES (4) | ES421290A1 (en) |
| FR (1) | FR2209578B1 (en) |
| GB (2) | GB1455998A (en) |
| HK (1) | HK60479A (en) |
| HU (2) | HU168763B (en) |
| IE (1) | IE40226B1 (en) |
| IL (1) | IL43773A (en) |
| KE (1) | KE2976A (en) |
| MY (1) | MY8000064A (en) |
| NL (1) | NL7316839A (en) |
| PH (2) | PH15197A (en) |
| SE (3) | SE403377B (en) |
| SU (4) | SU578001A3 (en) |
| YU (3) | YU35447B (en) |
| ZA (1) | ZA739207B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013169531A1 (en) * | 2012-05-09 | 2013-11-14 | Boehringer Ingelheim International Gmbh | Methods for making oxetan-3-ylmethanamines |
| LV14983B (en) * | 2013-10-15 | 2015-06-20 | Olainfarm, A/S | Method for producing intermediates of phenibut |
-
1973
- 1973-01-01 AR AR251422A patent/AR206306A1/en active
- 1973-12-04 IE IE2190/73A patent/IE40226B1/en unknown
- 1973-12-04 ZA ZA00739207A patent/ZA739207B/en unknown
- 1973-12-06 PH PH15299A patent/PH15197A/en unknown
- 1973-12-06 CA CA187,516A patent/CA1014560A/en not_active Expired
- 1973-12-07 ES ES73421290A patent/ES421290A1/en not_active Expired
- 1973-12-07 SU SU7301978316A patent/SU578001A3/en active
- 1973-12-07 HU HUEI511A patent/HU168763B/hu unknown
- 1973-12-07 CH CH17977A patent/CH614439A5/en not_active IP Right Cessation
- 1973-12-07 YU YU3184/73A patent/YU35447B/en unknown
- 1973-12-07 CA CA187,636A patent/CA1024150A/en not_active Expired
- 1973-12-07 SE SE7316586A patent/SE403377B/en unknown
- 1973-12-07 ES ES73421291A patent/ES421291A1/en not_active Expired
- 1973-12-07 NL NL7316839A patent/NL7316839A/xx not_active Application Discontinuation
- 1973-12-07 FR FR7343848A patent/FR2209578B1/fr not_active Expired
- 1973-12-07 YU YU3185/73A patent/YU36171B/en unknown
- 1973-12-07 AT AT1026073A patent/AT330773B/en not_active IP Right Cessation
- 1973-12-07 SU SU731977567A patent/SU587861A3/en active
- 1973-12-07 BE BE1005568A patent/BE808340A/en not_active IP Right Cessation
- 1973-12-07 AR AR251423A patent/AR212416A1/en active
- 1973-12-07 HU HUEI510A patent/HU168620B/hu unknown
- 1973-12-07 CH CH1720973A patent/CH605903A5/xx not_active IP Right Cessation
- 1973-12-07 DK DK663373AA patent/DK134717B/en not_active IP Right Cessation
- 1973-12-07 IL IL43773A patent/IL43773A/en unknown
- 1973-12-07 CH CH1720873A patent/CH619219A5/en not_active IP Right Cessation
- 1973-12-07 AT AT1026173A patent/AT332396B/en not_active IP Right Cessation
- 1973-12-08 BG BG025193A patent/BG21223A3/en unknown
- 1973-12-08 BG BG027548A patent/BG22386A3/en unknown
- 1973-12-08 JP JP14024573A patent/JPS5734835B2/ja not_active Expired
- 1973-12-08 JP JP48140246A patent/JPS5742633B2/ja not_active Expired
- 1973-12-08 DE DE2361340A patent/DE2361340C2/en not_active Expired
- 1973-12-08 BG BG028632A patent/BG26205A4/en unknown
- 1973-12-08 BG BG028633A patent/BG21409A3/en unknown
- 1973-12-10 GB GB2900376A patent/GB1455998A/en not_active Expired
- 1973-12-10 CY CY1017A patent/CY1017A/en unknown
- 1973-12-10 DD DD179119*A patent/DD115653A5/xx unknown
- 1973-12-10 DD DD175232A patent/DD110864A5/xx unknown
- 1973-12-10 CS CS738529A patent/CS222208B2/en unknown
- 1973-12-10 CS CS765892A patent/CS222209B2/en unknown
- 1973-12-10 GB GB5711373A patent/GB1455997A/en not_active Expired
- 1973-12-10 CS CS738528A patent/CS193480B2/en unknown
- 1973-12-10 DD DD175231A patent/DD109625A5/xx unknown
-
1975
- 1975-01-27 SU SU752100370A patent/SU648081A3/en active
- 1975-02-19 SU SU752106121A patent/SU663305A3/en active
- 1975-05-14 AR AR258799A patent/AR212012A1/en active
-
1976
- 1976-01-28 ES ES444716A patent/ES444716A1/en not_active Expired
- 1976-02-04 ES ES444911A patent/ES444911A1/en not_active Expired
- 1976-04-30 PH PH18384A patent/PH14923A/en unknown
-
1977
- 1977-02-17 SE SE7701796A patent/SE428378B/en unknown
- 1977-02-17 SE SE7701795A patent/SE417196B/en unknown
-
1979
- 1979-07-03 KE KE2976A patent/KE2976A/en unknown
- 1979-08-23 HK HK604/79A patent/HK60479A/en unknown
- 1979-09-06 CH CH805879A patent/CH630914A5/en not_active IP Right Cessation
-
1980
- 1980-04-22 YU YU1093/80A patent/YU36020B/en unknown
- 1980-12-30 MY MY64/80A patent/MY8000064A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY101353A (en) | Arylcarboxylic acid derivatives, the preparation and use thereof. | |
| GB1292768A (en) | Substituted benzylimidazolidinones and a process for the manufacture thereof | |
| MX9700273A (en) | Substituted benzamidines, their production and their use as medicaments. | |
| GB1344976A (en) | Aminoalkanol compounds and methods for their production | |
| ES450536A1 (en) | Chroman-4-ones and process for preparing same | |
| IE42978L (en) | Azabicyclo compounds | |
| IE40226B1 (en) | M-dioxane-5-methylamine analgesics | |
| ES424851A1 (en) | A procedure for preparing piperazine derivatives. (Machine-translation by Google Translate, not legally binding) | |
| ES8302733A1 (en) | Novel anthracycline derivative, process for production thereof, and pharmaceutical composition comprising said compound. | |
| ES450897A1 (en) | N-Tetrahydrofurfuryl-noroxymorphones, their salts, and analgesic compositions and methods employing them | |
| ES458812A1 (en) | Novel benzo *c* quinolines | |
| IE37717L (en) | N-BENZHYDRYL-N'-p-HYDROXYBENZYL-PIPERAZINES. | |
| ES447664A1 (en) | Cardenolide derivatives | |
| JPS5655382A (en) | Manufacture of ciss2*66dimethylmorpholine | |
| ES476420A1 (en) | Process for the preparation of o-phthalic aldehydes optionally having several substituents. | |
| GB1436377A (en) | Isoquinoline derivatives | |
| GB1387512A (en) | Method for the preparation of hydrogen peroxide | |
| ES423289A1 (en) | N-formyl and N-desmethyl leurosine derivatives | |
| IE38320L (en) | Nor-morphines and nor-codeines | |
| JPS5223518A (en) | Steel of extremeiy low yield point with excellent workability and non- aging property and production | |
| JPS52718A (en) | Process for producing magnets containing rare earth elements | |
| JPS5247988A (en) | Method of producing l-tartaric acid | |
| GB1437149A (en) | Spiro-compounds and a process for their preparation | |
| ES409555A1 (en) | A procedure for the obtaining of new derivatives of cefalosporine. (Machine-translation by Google Translate, not legally binding) | |
| IE45456L (en) | Aminoalkyl furan derivatives |